BIO

BioNTech

Stock
Stock
ISIN: DE000A0V9BC4
DE000A0V9BC4

Price

Precio

GRÁFICO POR

Información

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

Industrias
Biotechnology
Sector
Sanidad

Identificador

Número de Identificación Internacional de Valores (ISIN)
DE000A0V9BC4

Knockouts

Únase a la conversación